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Reactive oxygen species (ROS) are intensively studied because of their role in 
pathogenesis of variety of diseases. Database MEDLINE lists more than 
160,000 entries with terms “reactive oxygen species”, “ROS” or “free radical” 
and most of these studies deal with toxic effects of ROS. Concept of free 
radical toxicity explains, however, only one aspect of ROS function in the 
body. 
 
Growing body of evidence shows that low, subtoxic amounts of reactive 
oxygen species play indispensable physiological role, mainly in cell signalling. 
The concentration of ROS is a result of their production on one side and decay 
on the other side. Although there is couple of sources of ROS, NAD(P)H 
oxidases seem to be most important for signalling. Peroxiredoxins and 
thioredoxins are key players in scavenging of low levels of ROS. 
 
NAD(P)H oxidase 
NADPH oxidase is a well described enzyme of professional phagocytes. 
Oxidising NADPH, it reduces molecular oxygen to superoxide O2·
-. Superoxide 
is than converted to hydrogen peroxide and further to other reactive oxygen 
species. ROS formed in this process serve as microbicidal agents, 
chemoattractants and mediators of inflammation. They are also responsible for 
collateral damage to tissues in inflammatory response. 
 
Phagocyte NADPH oxidase is a multi-subunit enzyme. It consists of two 
membrane subunits, gp91PHOX (recently referred as Nox2) and p22PHOX. Both 
membrane subunits are combined to cytochrome b558. In order to activate 
NADPH oxidase, membrane subunits must be assembled with cytosolic 
subunits p47 PHOX, p40PHOX, p67PHOX and a small G-protein rac. Assembly of 
NADPH oxidase is triggered by fosforylation of p47PHOX dependent on 
proteinkinase C. 
 
Non-phagocyte NAD(P)H oxidase  
NADPH oxidase activity was found in many non-phagocyte cells. Indeed, 
many subunits of this enzyme were found in plenty of cell types from various 
tissues. Contemporarily, seven isoenzymes of NADPH oxidase are known. 
They are usually denoted according to gp91PHOX-like membrane subunit. 





Nox1 was the first discovered homologue of phagocyte NADPH oxidase. It is 
expressed in epithelial cells of colon, smooth muscle cells, uterus, prostate, 
kidneys, stomach and osteoclasts. Assembly with protein homologous to 
p47PHOX denoted as NOXO1 and another protein homologous to p67PHOX 
(NOXA1), as well as with p22PHOX and Rac is required for activity of Nox1. The 
physiological significance of Nox1 probably differs in various organs. It is 
probably a part of immune barrier of bowel. In other tissues it forms ROS 
rather for signaling. Nox1 also plays a role in angiotensin II induced arterial 








Fig. 1: NADPH oxidase of phagocytes 




Nox3 is required for function of vestibular and cochlear system. ROS produced 
by this enzyme are probably involved in formation of otoconia. Activity of this 
isoenzyme depends on p22PHOX; cytosolic subunits are not required, but 
increase its activity. 
 
Nox4 
Nox4 was originally described as “renal oxidase”, but it is present also in fetal 
liver, smooth muscle cells, osteoclasts, hematopoetic cells, adipocytes, and 
umbilical epithelial cells. In contrast to other isoenzymes it was found in the 
intracellular space. Nox4 forms a complex with p22PHOX but is probably 
independent on cytosolic subunits. Its activity is probably controlled by 
regulation of expression. Nox4 produces superoxide with simultaneous 
oxidation of not only NADPH, but also (and predominantly) NADH. it is also 
capable of direct reduction of molecular oxygen to hydrogen peroxide. Nox4 is 
involved in regulation of erythropoetin, in pathogenesis of diabetic nephropathy 




Nox5 was found due to its homology to cDNA of Nox2. It was detected in 
spleen, testis, in fetal tissues, and in lower amounts in ovarium, placenta, 
pancreas, smooth muscle cells, bone marrow and uterus. Its activity is 
regulated by calcium. The physiological role of Nox5 is unclear. 
 
Duox1 and 2 
Dual oxidases Duox1 and Duox2 are enzymes of thyroid gland. These proteins 
are much bigger than other NAD(P)H oxidases and except of NADPH oxidase 
activity posses also peroxidase activity. Both Duox1 and 2 reduce oxygen 
directly to hydrogen peroxide and are regulated by Ca2+. Duox1 was found 
also in respiratory tract, pancreas, placenta, prostate and testis. Duox2 is 
present in gastrointestinal tract and respiratory epithelium. 
 
Vascular oxidase 
NAD(P)H oxidases are the major source of superoxide in vessels. Nox1, 2, 4 
and 5 were found in all cellular types of vascular wall. All these enzymes 
contribute to total ROS production in vessels; therefore, the term “vascular 
oxidase” was introduced.  Most important properties of vascular oxidase 
include: 
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• Low activity. ROS production by vascular oxidase is about 1 – 10% of 
phagocytic one. 
• Non-stimulated activity. In contrast to phagocytic enzyme, vascular 
oxidase is characterised by basal activity. Regulation of vascular 
oxidase differs from phagocytic oxidase. 
• Subcellular localisation. A great part of vascular oxidase is found in 
intracellular space. Superoxide is however not release directly to 
cytosol but rather to vesicles and organells, including nucleus. 
• Early and late activation. Vascular oxidases may be activated in time 
period of several minutes to several hours. Early response is due to 
phosphorylation and enzyme assembly, late response is regulated by 
gene expression. 
• Role in signal transduction. Vascular oxidase produces low, subtoxic 
concentrations of ROS and plays a role in signal transduction. It 
stimulates some transcription factors and protein kinases and inhibits 
protein phosphatases. 
• Substradte specifity. Vascular oxidase uses not only NADPH but also 
NADH (especially Nox4). 
 
Expression of vascular oxidase differs in various vessels. Nox4 is generally 
found in all vascular cells in rather high concentrations. Nox2 is also 
expressed in all vascular cells except of media of large arteries: it is replaced 
by Nox1 there. Nox5 was found in human vascular smooth muscle cells, 
Duox2 was proved in media of human aorta. 
 
Vascular oxidase and signaling 
Proteinkinase C is probably the most important activator of vascular oxidase. 
Activity of this enzyme is also increased by phosphatidic acid, phospholipase 
D and arachidonic acid. Function of G-protein Rac (one of cytosolic subunits 
regulating several isoenzymes of vascular oxidase) depends on isoprenylation 
and is therefore influenced by activity of HMG-CoA reductase. Upstream to 
these signals are cytokins, growth factors and vasoactive peptides that mostly 
stimulate vascular oxidase. Activity of vascular oxidase is also increased by 
shear stress. Angiotensin II is one of most effective activators of vascular 
oxidase. 
Interestingly, ROS produced by vascular oxidase may further activate this 
enzyme in a pathway dependent on EGF. A stimulatory loop is closed in this 
way suggesting that vascular oxidase may act as a “switch” between two 
functional levels. 
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Vascular oxidase and nitric oxide 
Superoxide produced by NAD(P)H oxidases effectively reacts with NO. 
Peroxynitrite is formed in this reaction. Bioavailability of NO is decreased with 
inreasing superoxide production in this way. Important consequences for 
pathogenesis of arterial hypertension, atherosclerosis, cardial failure, 





Originally, this study aimed to describe the role of NAD(P)H oxidase in signal 
transduction, especially with respect to blood pressure regulation and to 
pathogenesis of cardiovascular disease. Following tasks had to bee solved: 
 
1. Techniques of cell culture had to be implemented. Cultures of 
individual cell types of vascular wall were to be introduced. 
2. To determine the differences in NAD(P)H oxidase activity in cells from 
normotensive and hypertensive individuals. 
3. Using specific inhibitors and activators, to study of the signal cascade 
controlling the NAD(P)H oxidase activity and differences of regulatory 
mechanisms between normotensive and hypertensive individuals. 
 
During these studies we encountered unexpected behavior of apocynin, a 
widely-used inhibitor of phagocyte NADPH oxidase that we intended to use 
also for studies on non-phagocyte NAD(P)H oxidase. Because of importance 
of these findings we studied the function of apocynin in a more detailed way. 
Results were published and attracted notable attention of other research 
groups; they create a major part of presented thesis. 
 
Original aims lost their importance in the meantime because most questions 
were answered by other teams. We therefore continued with studies on 
potential links between NAD(P)H oxidase and cardiovascular disease. 
Concretely, we have studied the effect of uric acid, an important risk factor of 
cardiovascular disorders but also a significant scavenger of ROS. 
 





Vascular fibroblasts were isolated from rat aortas using explanting culture, 
routinely fed twice a weak with F12K supplemented with 10% FBS and 
subcultured approximately once a weak, dilution factor 1:4. Cultures were 
prepared from normotensive rat (Wistar, WKY, and Brown norvergicus, BN). 
and from spontaneously hypertensive rat (SHR). Cells from passage 7 to 12 
were used for experiments. 
Vascular smooth muscle cells were isolated from rat (WKY, SHR) aorta 
cleared of endothelium and adventitia by enzymatic digestion. Cells were 
grown on thin layer collagene I and routinely fed twice a week with DMEM 
supplemented with 10% FBS and ECGS. Subcultures were performed once a 
week in ratio about 1:10. Cells from passage 5 to 12 were used for 
experiments. Contractibility of cultured cells was regularly assessed in order to 
check authenticity of culture. 
We tried several protocols for establishing culture of endothelial cells. Best 
results were achieved with cultivation of heart muscle microvascular 
endothelium, however we fail to scale up the culture so that it could be used 
for experiment. 
 
Isolation of peripheral leucocytes 
Leucocytes from peripheral blood were isolated by means of isopycnic 
centrifugal sedimentation using Histopaque or Percoll density gradients. 
 
Isolation of plasma membranes 
Plasma membrane enriched suspension was prepared using osmotic and 
ultrasonic disruption of cells followed by sequential ultracentrifugation. 
 
Reagents 
Serum treated zymosan was prepared from zymosan A from Saccharomyces 
cerevisiae. Swelled zymosan was repetitively incubated with pooled rat serum. 
 
2’,7’-dichlorofluorescein (DCFH) was prepared by hydrolysis of 2’,7’-
dichlorofluorescein diacetate (DCFH-DA) in alkaline environment. 
 
Martin Vejražka The role of NAD(P)H oxidase in signal transduction 
 
 8 
Pre-activated apocynin was prepared from apocynin by incubation with 
hydrogen peroxide and horse-radish peroxidase. Excess of hydrogen peroxide 
was then removed by action of catalase. Remaining peroxidase and catalase 
were removed by boiling and centrifugation. 
 
Assays for ROS production 
Assay with DCFH-DA. 2’,7’-dichlorofluorescein diacetate is a cell permeable 
probe for ROS, especially hydrogen peroxide and hydroxyl radical. It freely 
enters intact cells. Then, it is deesterified to DCFH by cytoplasmic esterases. 
DCFH is trapped in cells. ROS oxidise DCFH to fluorescent DCF. 
Fluorescence of DCF was measured at excitation wavelength 501 nm and 
emission wavelength 521 nm. 
 
Assay with WST-1. WST-1 is a water soluble tetrazolium derivative that is 
reduced by superoxide to a yellow formazan with absorption maximum at 450 
nm.WST-1 is not cell permeable. NAD(P)H oxidase activity was assessed as 
NADH / NADPH dependent reduction of WST-1 by cells or plasma 
membranes. The reaction was fully abandoned by superoxide dismutase and 
tiron (a specific synthetic scavenger of superoxide) proving that superoxide is 
the reducing species. WST-1 was not back-oxidised by hydrogen peroxide. 
 
Results and discussion 
Activity of NAD(P)H oxidase in vascular fibroblasts of 
normotensive and hypertensive rat. Effect of angiotensin II. 
Activity of both NADH and NADPH oxidase was significantly higher in cultured 
vascular fibroblasts from hypertensive animals compared to normotensive 
ones (Fig. 2). No difference was found between fibroblasts from both used 
normotensive strands (WKY and BN). 




Fig. 2: Activity of NAD(P)H oxidase in vascular fibroblasts from rat aorta. 
Cultured fibroblasts from hypertensive (SHR) rat had higher activity of both 
NADH oxidase and NADPH oxidase compared to normotensive (BN) 
fibroblasts. Ctrl: WST-1 reduction in absence of NADH and NADPH.  
*** p<0,001 (hypertensive vs. normotensive) 
 
 
Incubation of vascular fibroblasts with angiotensin II (100 nmol·l-1, three hours) 
hours lead to small but statistically significant increase of both NADH oxidase 
and NADPH oxidase activity in normotensive fibroblasts. In cells from 
hypertensive rat, both activities were rather lowered but the decrease was not 
statistically significant (Fig. 3). 
 
In next experiments we intended to describe the signaling pathway from 
angiotensin II to NAD(P)H oxidase activity. First measurements with apocynin, 
an inhibitor of phagocyte NADPH oxidase, gave surprising results and 

























Fig 3: Effect of angiotensin II on NAD(P)H oxidase activity in vascular 
fibroblasts of normotensive (BN) and hypertensive (SHR) rat. 
Fibroblasts were incubated with angiotensin II (100 nmol·l-1) for three hours. 
Activity of NAD(P)H oxidases is represented as % of controls untreated with 
angiotensin. * p<0,05. 
 
Effects of apocynin on ROS production by phagocyte and 
non-phagocyte cells 
Apocynin (4-hydroxy-3-methoxyacetophenone) is a methoxy-substituted 
catechol originally extracted from roots of Picrorrhiza kurroa, a small perennial 
herb that grows in the Himalayas. Like other methoxy-substituted catechols, it 
can decrease the production of superoxide by activated neutrophils and 
macrophages while the ability of phagocytosis remains unaffected. This 
compound is investigated as a possible anti-inflammatory drug 
Apocynin is also used as an experimental tool to inhibit phagocyte NADPH 
oxidase. We intended to use this compound, like other authors, to inhibit 
NADPH oxidase in non-phagocytes. The addition of apocynin, however, did 
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Effects of apocynin on ROS production by vascular fibroblasts 
Apocynin increased fluorescence of DCFH-DA treated fibroblasts (Fig. 4). The 
increase of fluorescence may be due to the oxidation of DCFH trapped in cells 
by ROS. However, such observation does not correspond to the fact that 
apocynin was assumed to reduce ROS formation by cells as it acts as an 
inhibitor of NADPH oxidase. 
We therefore tested whether the increase in fluorescence is not caused by a 
direct interaction of apocynin with DCFH or whether a fluorescing metabolite of 
apocynin is not formed. In a cell-free system, apocynin was mixed with DCFH 
deesterified in vitro (Fig. 5). Compared with previous experiments, the 
background of the probe was higher (in experiments with cells, only probes 
trapped in the cells gave the signal); however, the addition of apocynin did not 
cause any increase in fluorescence comparable with the previous experiment. 
This means that apocynin could not enhance fluorescence by direct interaction 





















Fig. 4: Effect of apocynin on ROS formation by vascular fibroblasts. 
Vascular fibroblasts (5×104 cells per millilitre) were treated with DCFH-DA (10 
µmol.l-1) or culture medium (MEM) for 30 minutes and washed with MEM. 
Fluorescence of DCF in counts per second (CPS) was then measured in 


























Fig. 5: Effect of apocynin on fluorescence of DCFH. 
2‘,7‘-dichlorofluorescin (DCFH) was prepared in vitro by de-esterification of 
DCFH-DA. Fluorescence of DCFH (20 µmol.l-1) in presence or absence of 
apocynin (Apo, 100 µmol.l-1) was measured in counts per second (CPS). 
 
 
In cells that were not treated with DCFH-DA, no increase in fluorescence after 
treatment with apocynin was observed (Fig. 4). Apocynin alone does not 
fluoresce in the examined range of spectrum and no fluorescing metabolite of 




Effects of apocynin on ROS formation by immune-stimulated phagocytes 
The findings stated above contradict the assumption that apocynin, as an 
NADPH oxidase inhibitor, should decrease ROS formation and consequent 
DCF fluorescence. In the literature, apocynin is well described as an inhibitor 
of respiratory burst in immune-stimulated macrophages. We therefore tested 
whether the respiratory burst of phagocytes is suppressed by apocynin under 
the conditions used in the previous experiment.  
When apocynin was added to macrophages immune-stimulated with serum-
treated zymosan (STZ), ROS production increased in the first minutes. Then it 
slowed down rapidly and after 15 minutes, ROS formation was lower than 
during absence of apocynin (Fig. 6). The addition of fresh apocynin led to a 
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new increase of ROS formation; therefore, a decrease in the rate of ROS 
production could not be caused by reaching the detection limit of the method 


















Fig 6: Effect of apocynin on oxidation of DCFH-DA by macrophages 
stimulated with STZ. 
Macrophages pre-treated with DCFH-DA were immune-stimulated with STZ (1 
mg.ml-1) in presence or absence of apocynin (Apo, 100 µmol.l-1). Rate of ROS 
formation was measured as rate of increase in DCF fluorescence per second. 
 
 
These results suggest that fresh apocynin does not act as an NADPH oxidase 
inhibitor but is, in contrast, capable of stimulating ROS production. However, it 
can be metabolized to another compound that suppresses ROS formation. 
 
Effect of pre-activated apocynin on ROS production 
As stated above, apocynin did not inhibit ROS production in fibroblasts. In 
macrophages, inhibition was delayed most probably because apocynin had to 
be converted to its dimer through reaction with products of immune stimulated 
phagocytes. We further tested the effect of apocynin pre-activated in vitro with 
horseradish peroxidase and hydrogen peroxide. It had an immediate inhibitory 
effect on the oxidation of DCFH-DA by both vascular fibroblasts (Fig. 7) and 
STZ stimulated macrophages. 
 
 


















Fig. 7: Effect of apocynin pre-activated with HRP and hydrogen peroxide 
on ROS formation by vascular fibroblasts. 
Vascular fibroblasts were treated with DCFH-DA, washed and resuspended in 
pre-activated apocynin or MEM. Fluorescence of DCF was measured in 















Fig. 8: Effect of scavengers on apocynin stimulated ROS production. 
Fluorescence of controls without apocynin and inhibitors is 100%. * p<0,05 
compared to apocynin. 




Effect of ROS scavengers and NADPH-oxidase inhibitors 
Tiron, a specific cell-permeable superoxide scavenger, almost completely 
abolished the influence of apocynin on oxidation of DCFH by vascular 
fibroblasts. Superoxide dimutase (SOD) and catalase also at least partially 
suppressed the effect of apocynin (Fig. 8). 
The stimulatory effect of apocynin on ROS formation by vascular fibroblasts 
was significantly diminished by diphenylene iodinium (DPI), too. DPI is an 
inhibitor of flavoproteins and lacks scavenging properties. All these findings 
strongly support the hypothesis that apocynin enhanced fluorescence 
corresponds to increased ROS production. The species increased after 
apocynin treatment is most probably superoxide that consequently dismutes to 
form hydrogen peroxide. 
 
Discussion on experiments with apocynin 
Apocynin is a widely used inhibitor of phagocyte NADPH oxidase. NADPH 
oxidase is also present in non-phagocyte cells where it plays an important role 
in ROS production for cell signaling. As phagocyte and non-phagocyte NADPH 
oxidases share most subunits and properties, we tried to use apocynin as an 
NADPH oxidase inhibitor in experiments with vascular cells. Surprisingly, 
apocynin had no inhibitory effect on ROS production but even enhanced ROS 
formation. 
The reactive oxygen species formed after apocynin treatment is most probably 
superoxide. Increased ROS production was completely abolished by 
superoxide-specific scavenger tiron and diminished by superoxide dismutase. 
Catalase reduced the effect of apocynin as well. It may be supposed that the 
originally formed superoxide dismutes to oxygen and hydrogen peroxide that 
consequently oxidizes DCFH to fluorescent DCF. Interestingly, DPI, a non-
scavenging inhibitor of NADPH oxidase, diminished the effect of apocynin as 
well suggesting that NADPH oxidase could be the source of superoxide. 
However DPI is not a specific inhibitor of NADPH oxidase but acts on all 
flavoproteins. It seems likely that apocynin stimulates ROS production by an 
enzyme that contains the flavine group or is regulated by a flavoprotein. 
In immune-stimulated phagocytes, the role of apocynin is more complex. First, 
it stimulates ROS formation, however, after a certain period its behavior 
changes and inhibition of ROS yield occurs. When apocynin is “pre-activated” 
with hydrogen peroxide and a peroxidase prior to use, it immediately acts as 
an inhibitor both in phagocytes and non-phagocytes. It seems that the 
activation of apocynin consists of its oxidation by H2O2 in presence of a 
peroxidase activity, either externally added or produced by macrophages.
On the other hand, there are studies that prove the inhibitory effects of 
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apocynin on ROS formation in non-phagocytes as well. The conditions under 
which these experiments were performed, however, are different: cells or 
tissues were treated with apocynin several hours or even several days before 
measurement was begun. It can be assumed that slower production of H2O2 
by non-phagocytes was sufficient in these cases and peroxidase activity was 
probably replaced by pseudo-peroxidase effect of iron and other transition 
metals present as ubiquitous contaminants. 
The capability of apocynin to inhibit ROS formation first after activation by 
peroxidase and hydrogen peroxide might be of pharmacological importance. 
Apocynin is activated in the locus of inflammation only where there is both free 
leukocyte myeloperoxidase and hydrogen peroxide. In this case apocynin acts 
as an anti-inflammatory agent. Phagocytes that are not immune activated 
cannot be inhibited in this way. 
The question remains whether the increase in ROS formation after treatment 
with fresh apocynin might play any role. Cell produced ROS have important 
signaling properties that are associated with many cytokines and growth 
factors. Apocynin could act in this manner not only as an anti-inflammatory 
drug by suppressing microcide and cytotoxic agent formation but might at the 
same time support cell proliferation and tissue reparation. 
 
Results of our experiments with apocynin were published in Biochimica et 
Biophysica Acta, General Subjects in 2005. This paper was awarded as one of 
top-ten most downloaded articles of the year 2005. Several authors extended 
our study. Reinehr et al. studied the effect of apocynin on hepatocytes. These 
cells posses a high peroxidase activity and so inhibitory effect of apocynin 
prevailed. Riganti et al. confirmed that apocynin increases oxidative stress and 
production of hydrogen peroxide.Ximenes et al. suggested that the inhibitory 
derivative of apocynin is its radical formed by peroxidase catalysed oxidation. 
 
Effects of uric acid on vascular oxidase activity 
Increased serum uric acid (UA) is linked to higher cardiovascular risk. It is an 
independent risk-factor for arterial hypertension, especially for essential 
hypertension in young patientsand its complications. Relationships between 
increased serum UA and coronary arterial disease, atherosclerosis, cerebral 
stroke, endothelial dysfunction and renal disease have also been established. 
Interestingly, oxidative stress plays a role in pathogenesis of all of disorders 
mentioned above. On the other hand, UA possesses important antioxidant 
properties: it is a potent scavenger of superoxide, hydroxyl radical and singlet 
oxygen, and acts as an iron chelator. UA is even believed one of the most 
important antioxidants of blood plasma. 
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 Association of increased UA and cardiovascular disease could seem to be 
contradictory to antioxidant properties of UA. We tested the hypothesis that UA 
could stimulate NAD(P)H oxidases of vascular wall and thus increase 
production of reactive oxygen species. 
 
 
Fig. 9: NADH oxidase activity in plasma membranes of vascular smooth 
muscle cells isolated from aortas of normotensive (WKY) and 
spontaneously hypertensive (SHR) rat. 
Cells were treated with high concentration of uric acid (1 mM, UA) for 48 
hours. ** p<0.01 
 
 
Treatment of vascular smooth muscle cells from normotensive rat (Wistar) with 
uric acid (1mmol/L) stimulated superoxide production by both NADH and 
NADPH oxidase in isolated plasma membranes (Fig. 9A). NADH oxidase 
activity increased to 190% of controls. Basal activity of NADPH oxidase was 
much lower (Fig. 10A); after uric acid treatment it increased to 180%. 
In vascular smooth muscle cells from hypertensive rat (SHR), the activity of 
both oxidases and effect of UA differed. Generally, UA had no significant effect 
on the NADH or NADPH oxidase activity (Fig. 9B and 10B). Interestingly, 
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activity in normotensive cells. On the other hand, NADH oxidase activity of 




Fig. 10: NADPH oxidase activity in plasma membranes of vascular 
smooth muscle cells isolated from aortas of normotensive (WKY) and 
spontaneously hypertensive (SHR) rat. 
Cells were treated with high concentration of uric acid (1 mM, UA) for 48 
hours. ** p<0.01 
 
Both uric acid free environment and medium with 1 mmol.l-1 of uric acid do not 
correspond to physiological situation: plasmatic concentration of UA is 150 
µmol·l-1 in rat. Therefore, we assessed the effect of uric acid in various 
concentrations between these values on NAD(P)H oxidase activity. 
Superoxide production by NADH oxidase was lowest for UA concentrations 
near to physiological values (Fig. 11). NADPH oxidase activity was much lower 
in general; least superoxide was formed when cells were grown in medium 























Fig. 11: Effect of uric acid on NADH oxidase activity in VSMC. 
Cells were treated with indicated concentration of uric acid. Activity of NADH 
oxidase was assessed in isolated plasma membranes. 
 
Discussion on the effect of uric acid on HAD(P)H oxidase 
Uric acid is linked to increased cardiovascular risk despite the fact that it is a 
potent antioxidant and therefore might be rather protective. We showed that 
UA significantly stimulates superoxide production by plasma membrane 
NAD(P)H oxidase in vascular smooth muscle cells of normotensive rat aorta. 
Nox4 which prevails in VSMC has higher NADH oxidase than NADPH oxidase 
activity. This is in agreement with prevailing NADH oxidase activity in our 
results. 
In hypertensive VSMC, UA did not stimulate NAD(P)H activity. Interestingly, 
the basal activity of NADH oxidase in hypertensive cells was comparable with 
non-stimulated normotensive cells while NADPH oxidase activity of 
hypertensive cells was similar to UA-stimulated normotensive cells. This 
strongly suggests that NADH and NADPH oxidase activities are carried by (at 













0 200 400 600 800 1000













Fig. 12: Effect of uric acid on NADPH oxidase activity in VSMC. 
Cells were treated with indicated concentration of uric acid. Activity of NADH 
oxidase was assessed in isolated plasma membranes. 
 
 
Several authors have already suggested that low concentrations of UA have 
antioxidant properties while high concentrations are rather pro-oxidant. It has 
even been found in some epidemiological studies that the relation between UA 
and cardiovascular risk is a J-shaped curve. This is in concordance with our in 
vitro model (Fig. 11). An important property of ROS producing NAD(P)H 
oxidase is that ROS further stimulate its activity. Thus, it may be suggested 
that low concentrations of UA decrease NAD(P)H oxidase activity due to its 























1. Experimental models for studies on NAD(P)H oxidase in cultured 
vascular smooth muscle cells and fibroblasts were introduced. 
Cultures of vascular cells from normotensive and hypertensive rat 
were established. We failed to introduce similar model with endothelial 
cells. 
 
2. Activity of NAD(P)H oxidase in cultured fibroblasts from rat aorta was 
higher in cells from hypertensive animal (SHR) compared to 
normotensive ones (WKY, BN). 
3. NAD(P)H oxidase of vascular fibroblasts was stimulated by 
angiotensin II in cells from normotensive rat. Angiotensin II had no 
significant effect on cells from hypertensive rat. 
 
4. Apocynin, literally well described as inhibitor of phagocyte NADPH 
oxidase, increases ROS production (namely production of superoxide) 
in some cells. Increase of ROS production appears in cells lacking 
peroxidase activity and/or low production of hydrogen peroxide. 
Superoxide producing system is inhibited with DPI, an inhibitor of 
flavoenzymes. 
5. Inhibiting of phagocyte NADPH oxidase is not a property of apocynin 
itself. A product of apocynin raising by action of hydrogen peroxide in 
presence of peroxidase is responsible for NAD(P)H oxidase inhibition. 
6. Different effecr of apocynin on ROS production in phagocytes and 
non-phagocyte cells may be of pharmacological importance for 
intended use of apocynin as an antiinflammatory drug. 
 
7. Uric acid influences NAD(P)H oxidase activity in vascular smooth 
muscle cells. Low concentrations of uric acid (lower than 
physiological) inhibit superoxide production by NAD(P)H oxidase while 
high concentrations stimulate ROS production. 
8. Uric acid had no significant effect on VSMC from hypertensive rat. 
9. Antioxidant effect of low and pro-oxidative effect of high 
concentrations of uric acid could explain current controversies 
between scavenging properties of uric acid and the fact that uric acid 
is a risk factor for cardiovascular disease. 




Reactive oxygen species are usually assumed as dangerous, cytotoxic 
substances included in pathogenesis of variety of diseases due to their ability 
to damage biomolecules. However, ROS also play an indispensable role in 
many physiological processes. Low concentrations of ROS are involved in 
signal transduction as a part of pathways regulating protein phosphorylation, 
gene expression, NO availability or intracellular Ca2+. They are important for 
cell cycle control and apoptose. In the last years, the role of ROS in regulation 
of vascular tonus is intensively studied. 
NAD(P)H oxidases are supposed the major source of ROS. These are 
enzymes similar to phagocyte NADPH oxidase, a key enzyme of phagocyte 
respiratory burst in immune response. We have studied NAD(P)H oxidase of 
vascular wall in normotensive and hypertensive rat. Activity of superoxide 
production by NAD(P)H oxidase differ between cells from normotensive and 
hypertensive rat. Control of NAD(P)H oxidase activity is also changed in 
hypertensive animals, at least with respect to the effect of angiotensin II and 
uric acid. 
In our experimental work, we encountered unexpected properties of apocynin, 
a known inhibitor of phagocyte NADPH oxidase. We proved that apocynin can 
increase ROS production. The reason is that NAD(P)H oxidase is not inhibited 
directly by apocynin but rather by a metabolite of this compound. Apocynin is 
converted to the active inhibitor by action of hydrogen peroxide and a 
peroxidase. 
We also performed pilot studies on the effect of uric acid on NAD(P)H oxidase 
activity. Uric acid in low concentrations decreases while in high concentrations 
increases superoxide production in vascular smooth muscle cells. This finding 
could explain current controversies between scavenging properties of uric acid 
and increased cardiovascular risk in hyperuricemia. 
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